The Anxiety and Depression: 21st Neuropharmacology Conference will take place November 10-11 in Virginia, USA as a satellite to the 2011 Meeting of the Society for Neuroscience.

Anxiety and depression are amongst the most common brain disorders, with significant consequences for the individual and society. The 21st Neuropharmacology annual conference will bring together the leading experts in the field of psychiatry, neuroscience and pharmacology to present and discuss the latest research.

Abstracts are invited for poster and oral presentations on the following symposium topics:

Emerging Therapeutic Targets in Depression
Emerging Therapeutic Targets in Anxiety
Animal Models
Genetics and Epigenetics in Depression and Anxiety
Imaging
Developmental Aspects of Anxiety and Depression
Neuronal Circuits Underlying Anxiety and Depression
Fear Extinction
Mechanism of Action of Antidepressants and Anxiolytics

Conference Chairs
Hanns Möhler, University and ETH Zurich, Switzerland
Eric Nestler, Mount Sinai Medical Center, NY, USA

Conference Committee
John Cryan, University College Cork, Ireland
Athina Markou, University of California, San Diego, USA